Free Interactive PDF

Biological Endpoint Evidence Route Planner

Record device and contact facts, identify the biological questions that must be addressed, and map each one to a traceable evidence route without turning the exercise into a mandatory test list.

Get Version 1.2 See an Actual Page

Tool at a glance

Device & Contact Frame

Freeze the represented finished device, clinical contact, cumulative duration, population, and jurisdiction before selecting evidence.

15 Biological Questions

Mark each original question Address, N/A, or Open with a visible evidence reference or device-specific rationale.

10 Evidence-Route Rows

Map existing data, chemistry and toxicology, targeted testing, reasoned justification, or other qualified evidence.

What It Helps You Do

Separate the biological question from the evidence route

An endpoint can require evaluation without automatically requiring a new biological test. This planner helps a team show what matters for the specific device, how each question is addressed, what remains open, and where FDA, ISO 10993, or EU positioning may differ.

Need the reasoning first?Read the guide

Freeze the exposure scenario

Record body contact, direct or indirect exposure, frequency, cumulative duration, use population, configuration, and planning purpose.

Identify the real questions

Use original biological questions covering cellular, local, systemic, blood, genetic, carcinogenic, reproductive, and degradation concerns.

Route the evidence

Connect the selected question to evidence, applicability, limitations, ownership, and status instead of copying a generic test matrix.

Challenge the plan

Test whether N/A rationales, prior evidence, chemistry and toxicology, proposed tests, and market-specific positions are genuinely defensible.

Avoid false certainty

The planner does not reproduce ISO tables, prescribe tests, grant a waiver, or establish biological safety or regulatory acceptance.

Get Version 1.2

Enter your email and the download opens immediately on the next page.

Best For

  • BEP and BER endpoint-evidence planning
  • Legacy-file remediation and no-new-testing rationales
  • FDA, EU MDR, and cross-market planning discussions

What Happens Next

  • Download the eight-page interactive PDF
  • Record each question and its honest evidence status
  • Route the remaining gaps to the smallest justified next step

The optional update checkbox is not required to receive the tool. Marketing emails are sent only when you select it.